Table 1 Baseline characteristics of participants at screening
Characteristics | GA2-MB (n = 10) | Placebo (n = 5) | Total (n = 15) |
---|---|---|---|
Age | |||
Mean (s.d.) | 24 (3) | 24 (5) | 24 (4) |
Median (range) | 23 (21–30) | 25 (19–31) | 23 (19–31) |
Sex | |||
Male (%) | 4 (40.0) | 3 (60.0) | 7 (46.7) |
Female (%) | 6 (60.0) | 2 (40.0) | 8 (53.3) |
BMI | |||
Mean (s.d.) | 23.9 (3.3) | 22.7 (2.1) | 23.5 (2.9) |
Median (range) | 23.8 (19.4-28.6) | 23.7 (20.3-25.0) | 23.7 (19.4-28.6) |